ATG-037 / Antengene 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ATG-037 / Antengene
KEYNOTE-E73, NCT05205109: A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors

Recruiting
1
98
RoW
ATG-037, KEYTRUDA ®( Pembrolizumab), MK-3475
Antengene Therapeutics Limited, Merck Sharp & Dohme LLC
Locally Advanced or Metastatic Solid Tumors
08/27
02/28

Download Options